In studies using independent patient groups, both changes in complement ratio (C3/C4)22 and the categorisation of neutrophil to lymphocyte ratio (NLR)23, have been suggested as ways to distinguish SLE patient groups. This evidence concerns the gene C4A and systemic lupus erythematosus.